A-TRAIN
National Cancer Center, Japan
National Cancer Center, Japan
Institut Paoli-Calmettes
Centre Hospitalier Universitaire Vaudois
Kaiser Permanente
University Medical Center Groningen
Multitude Therapeutics Inc.
Immix Biopharma, Inc.
Kineta Inc.
Namida Lab
Shanghai Yunying Medical Technology
MiRXES Pte Ltd
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Impact Therapeutics, Inc.
OncXerna Theraputics, Inc.
Charite University, Berlin, Germany
Blue Note Therapeutics
Main Line Health
Imperial College London
Assistance Publique - Hôpitaux de Paris
Weprom
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Shanghai Fengxian District Central Hospital
University Hospital Southampton NHS Foundation Trust
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Aalborg University
Samyang Biopharmaceuticals Corporation
Placon Therapeutics
Xuanwu Hospital, Beijing
Quantgene Inc.
Merrimack Pharmaceuticals
Poveda, Andrés, M.D.
SPGO Research Mannheim GmbH
Rigshospitalet, Denmark
Shenzhen Second People's Hospital
Women's College Hospital
Chinese PLA General Hospital
Arno Therapeutics
Rutgers, The State University of New Jersey
University of Aarhus
National Cancer Institute (NCI)
Radboud University Medical Center
Korean Breast Cancer Study Group
Hadassah Medical Organization
The University of Texas Health Science Center, Houston
Poniard Pharmaceuticals
National Cancer Institute (NCI)